Top Story

FDA approves Iluvien for treatment of DME

September 29, 2014

The U.S. Food and Drug Administration has approved Iluvien for the treatment of diabetic macular edema in patients previously treated with corticosteroids who did not have a significant increase in IOP, Alimera Sciences announced in a press release.

Iluvien (fluocinolone acetonide implant 0.19 mg) was approved with no requirement that patients undergo cataract surgery, according to the release.

Top 5 stories from Vision Expo West

September 26, 2014
Primary Care Optometry News reporters attended Vision Expo West in Las Vegas last week and collected the latest news in ophthalmic technology, treatment strategies and…

Electronic integration is here

September 25, 2014
Growing up in the middle of the last century, I was fascinated by the discovery and invention of new things that changed the world. As a young lad working in my…
Meeting News Coverage

Providers align, quality matters in health care reform

September 23, 2014
LAS VEGAS – “All providers are now on the same side of the table: doctors, hospitals, other ancillary providers. If they do well taking care of patients…
CME
figure

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »

Filter By:

figure FDA approvals

FDA approves Iluvien for treatment of DME

September 29, 2014
The U.S. Food and Drug Administration has approved Iluvien for the treatment of diabetic macular edema in patients previously treated with…

Top 5 stories from Vision Expo West

September 26, 2014
Primary Care Optometry News reporters attended Vision Expo West in Las Vegas last week and collected the latest news in ophthalmic technology…

Electronic integration is here

September 25, 2014
Growing up in the middle of the last century, I was fascinated by the discovery and invention of new things that changed the world. As a young lad…
Meeting News Coverage

Providers align, quality matters in health care reform

September 23, 2014
LAS VEGAS – “All providers are now on the same side of the table: doctors, hospitals, other ancillary providers. If they do well taking…
FDA News

Eylea earns breakthrough therapy designation from FDA

September 18, 2014
The U.S. Food and Drug Administration has granted breakthrough therapy designation to Eylea for the treatment of diabetic retinopathy in patients…
FDA News

Herantis Pharma pursues phase 2 study for dry eye treatment

September 15, 2014
The U.S. Food and Drug Administration has cleared the Investigational New Drug application of Herantis Pharma for a phase 2 clinical study of Cis-UCA…
Breaking News

Jetrea approved in South Korea for symptomatic vitreomacular adhesion

September 8, 2014
Jetrea has been approved in South Korea for the treatment of symptomatic vitreomacular adhesion, according to a ThromboGenics press release.This is…
Breaking News

Ozurdex approved in EU for treatment of DME

September 2, 2014
The European Commission has extended marketing authorization for Ozurdex for the treatment of diabetic macular edema in certain patients, according…

California optometry scope expansion bill tabled until 2015

August 27, 2014
A bill in California that intended to allow optometrists to use therapeutic lasers and pharmaceutical agents approved by the U.S. Food and Drug…
FDA News

FDA grants labeling extension to class 3 contact lenses, IOLS

August 26, 2014
The U.S. Food and Drug Administration announced on its website that the Center for Devices and Radiological Health has granted a 1-year extension of…
More Headlines »